Cargando…
Current molecular biomarkers evaluation in gastric/gastroesophageal junction adenocarcinoma: pathologist does matter
The comprehensive molecular characterization of gastric and gastroesophageal junction adenocarcinomas has led to the improvement of targeted and more effective treatments. As a result, several biomarkers have been introduced into clinical practice and the implementation of innovative diagnostic tool...
Autores principales: | Businello, Gianluca, Angerilli, Valentina, Lonardi, Sara, Bergamo, Francesca, Valmasoni, Michele, Farinati, Fabio, Savarino, Edoardo, Spolverato, Gaya, Fassan, Matteo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852175/ https://www.ncbi.nlm.nih.gov/pubmed/35834132 http://dx.doi.org/10.1007/s13304-022-01330-5 |
Ejemplares similares
-
Association of CLDN18 Protein Expression with Clinicopathological Features and Prognosis in Advanced Gastric and Gastroesophageal Junction Adenocarcinomas
por: Pellino, Antonio, et al.
Publicado: (2021) -
Molecular subtyping of gastroesophageal dysplasia heterogeneity according to TCGA/ACRG classes
por: Angerilli, Valentina, et al.
Publicado: (2022) -
The ideal reporting of RAS testing in colorectal adenocarcinoma: a pathologists’ perspective
por: Malapelle, Umberto, et al.
Publicado: (2023) -
MicroRNAs as Predictive Biomarkers of Resistance to Targeted Therapies in Gastrointestinal Tumors
por: Angerilli, Valentina, et al.
Publicado: (2021) -
Molecular Landscapes of Gastric Pre-Neoplastic and Pre-Invasive Lesions
por: Businello, Gianluca, et al.
Publicado: (2021)